Drug discovery for primary amebic meningoencephalitis: from screen to identification of leads.

Introduction: Naegleria fowleri is responsible for primary amebic meningoencephalitis (PAM) which has a fatality rate of >97%. Because of the rarity of the disease, pharmaceutical companies do not ...